Over 40 yrs ago, Dr Steve Zinner took me under his wing and introduced me to the hollow fiber PK-PD system he developed- now foundational in antibiotic R&D. And he is still presenting work ESCMID ! Long may you run my dear friend.

We discuss doing a better job communicating on #AMR . Messaging 'it's a really big problem” has failed to reform pricing to feed investment for new drugs. Confuses policymakers.Find out why AMR is more like “rare” dx.Antimicrobials Working Group SIDP CARB-X Global Antibiotic R&D Partnership (GARDP) IDSA Pew Health

Getting new antibiotics is fundamentally a revenue & insurance problem. Restore the investment/innovation/revenue cycle with new tools for quantifying value. Same policy talking points aren't working. Step-up the game. Global Antibiotic R&D Partnership (GARDP) Antimicrobials Working Group AMR Action Fund Pew Health SIDP

Can anyone explain to me why they have these talks in noisy traffic areas with uncomfortable/ limited seating where larger halls just around the corner sit empty? IDWeek please—let’s not do this anymore! Debbie Goff SIDP

Beta-lactamase inhibitors have been an important strategy for combatting #AMR . Want to finally see comparative head-to-head data on investigational & marketed beta-lactamase inhibitors? We publish results here… journals.asm.org/doi/10.1128/aa…

Class act or what!? Jason Pogue Neil Clancy

It just doesn’t get any better than this! Thanks to Julie Ann Justo and SIDP for a great discussion.

Indeed- enjoyed our discussion David!

Both Shionogi and @Qpex share a deep commitment to innovation in the development of products for infectious diseases. Antimicrobials Working Group CARB-X SIDP IDSA AMR Action Fund Kevin Outterson BARDA AMR IndustryAlliance BEAM Alliance Timothy Jinks Global Antibiotic R&D Partnership (GARDP) Pearl Freier

Must be my lucky day. #Wordle 715 1/6

🟩🟩🟩🟩🟩

This is particularly egregious when it’s antibiotic therapy in fragile patients. ⁦SIDP⁩ ⁦Antimicrobials Working Group⁩ ⁦IDSA⁩ ⁦CARB-X⁩ ⁦AMR Action Fund⁩ ⁦@Wellcome_AMR⁩ ⁦Sen. Lisa Murkowski⁩ ⁦Congressman Raul Ruiz, M.D.⁩ washingtonpost.com/wellness/2023/…

Also, xeruborbactam (formerly QPX7728) Phase 1 PK for IV and oral dosing in Posters #216 & 218, and PK-PD results on #614-5. SIDP @IDWeek2022 #IDWeek2022 IDSA Antimicrobials Working Group

Going to be a busy week. Congrats and thanks to the Qpex Team and our collaborators. Neil Clancy Ryan Shields Global Antibiotic R&D Partnership (GARDP) IDSA #IDWeek2022 BARDA SIDP #AMR #IDTwitter Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 𝘼𝙘𝙞𝙣𝙚𝙩𝙤𝙗𝙖𝙘𝙩𝙚𝙧 𝙗𝙖𝙪𝙢𝙖𝙣𝙣𝙞𝙞 #TwitteRx

All you need to see to understand #MICROBE2022 is not the clinical and scientific meeting for antibiotics that #ICAAC used to be…

Yes it’s broken.. but now the entire biotech sector has downturned. What must we do to fix it? (Its going to be early, so get a double shot that morning!)

This is going to be fun. Looking forward to discussions with Mariana Castanheira and Amy Mathers. #IDTwitter SIDP #Microbe2022